Search Results

Filter
  • 1-10 of  725 results for ""DESIGNER drugs""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Size-reduced DREADD derivatives for AAV-assisted multimodal chemogenetic control of neuronal activity and behavior.

  • Authors : Miyake T; Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyō-ku, Kyoto 606-8501, Japan. Electronic address: .; Tanaka K

Subjects: Dependovirus*/Dependovirus*/Dependovirus*/genetics ; Neurons*/Neurons*/Neurons*/drug effects ; Neurons*/Neurons*/Neurons*/metabolism

  • Source: Cell reports methods [Cell Rep Methods] 2024 Oct 21; Vol. 4 (10), pp. 100881.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918227360606676 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Protective Effect of Aldo-keto Reductase 1B1 Against Neuronal Cell Damage Elicited by 4'-Fluoro-α-pyrrolidinononanophenone.

  • Authors : Morikawa Y; Forensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu, Japan.; Miyazono H

Subjects: Aldehyde Reductase/Aldehyde Reductase/Aldehyde Reductase/*biosynthesis ; Butyrophenones/Butyrophenones/Butyrophenones/*toxicity ; Designer Drugs/Designer Drugs/Designer Drugs/*toxicity

  • Source: Neurotoxicity research [Neurotox Res] 2021 Aug; Vol. 39 (4), pp. 1360-1371. Date of Electronic Publication: 2021 May 27.Publisher: Springer Country of Publication: United States NLM ID: 100929017 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Non-invasive chemogenetics.

  • Authors : Menard C; Department of Psychiatry and Neuroscience, Faculty of Medicine & CERVO Brain Research Center, Université Laval, Quebec City, Quebec, Canada. .; Russo SJ

Subjects: Designer Drugs* ; Neurons*

  • Source: Nature biomedical engineering [Nat Biomed Eng] 2018 Jul; Vol. 2 (7), pp. 467-468.Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print Cited Medium: Internet ISSN: 2157-846X

Record details

×
Academic Journal

Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys.

  • Authors : Nagai Y; Department of Functional Brain Imaging, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.; Miyakawa N

Subjects: Behavior, Animal/Behavior, Animal/Behavior, Animal/*drug effects ; Brain/Brain/Brain/*drug effects ; Clozapine/Clozapine/Clozapine/*analogs & derivatives

  • Source: Nature neuroscience [Nat Neurosci] 2020 Sep; Vol. 23 (9), pp. 1157-1167. Date of Electronic Publication: 2020 Jul 06.Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9809671 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.

  • Authors : Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse (NIDA) Intramural Research Program, Baltimore, MD 21224, USA.; Bonaventura J

Subjects: Brain/Brain/Brain/*metabolism ; Clozapine/Clozapine/Clozapine/*analogs & derivatives ; Designer Drugs/Designer Drugs/Designer Drugs/*pharmacology

  • Source: Science (New York, N.Y.) [Science] 2017 Aug 04; Vol. 357 (6350), pp. 503-507.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Optogenetics and Chemogenetics.

  • Authors : Vlasov K; Massachusetts General Hospital, Boston, MA, United States; Massachusetts Institute of Technology, Cambridge, MA, United States.

Subjects: Anesthetics, General/Anesthetics, General/Anesthetics, General/*pharmacology ; Brain/Brain/Brain/*drug effects ; Designer Drugs/Designer Drugs/Designer Drugs/*pharmacology

  • Source: Methods in enzymology [Methods Enzymol] 2018; Vol. 603, pp. 181-196. Date of Electronic Publication: 2018 Mar 19.Publisher: Academic Press Country of Publication: United States NLM ID: 0212271 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro.

  • Authors : Xu P; Drug Intelligence and Forensic Center, Ministry of Public Security, Beijing, China.; Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, China.

Subjects: Benzylamines/Benzylamines/Benzylamines/*toxicity ; Designer Drugs/Designer Drugs/Designer Drugs/*toxicity ; Hallucinogens/Hallucinogens/Hallucinogens/*toxicity

  • Source: Neurotoxicity research [Neurotox Res] 2019 May; Vol. 35 (4), pp. 993-998. Date of Electronic Publication: 2019 Feb 26.Publisher: Springer Country of Publication: United States NLM ID: 100929017 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Chemogenetic Targeting of Dorsomedial Direct-pathway Striatal Projection Neurons Selectively Elicits Rotational Behavior in Mice.

  • Authors : Bay Kønig A; Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.; Ciriachi C

Subjects: Designer Drugs/Designer Drugs/Designer Drugs/*pharmacology ; Neostriatum/Neostriatum/Neostriatum/*physiology ; Neural Pathways/Neural Pathways/Neural Pathways/*physiology

  • Source: Neuroscience [Neuroscience] 2019 Mar 01; Vol. 401, pp. 106-116. Date of Electronic Publication: 2019 Jan 19.Publisher: Elsevier Science Country of Publication: United States NLM ID: 7605074 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Designer Drug 3-Fluoromethcathinone Induces Oxidative Stress and Activates Autophagy in HT22 Neuronal Cells.

Subjects: Autophagy/Autophagy/Autophagy/*drug effects ; Designer Drugs/Designer Drugs/Designer Drugs/*toxicity ; Neurons/Neurons/Neurons/*drug effects

  • Source: Neurotoxicity research [Neurotox Res] 2018 Oct; Vol. 34 (3), pp. 388-400. Date of Electronic Publication: 2018 Apr 14.Publisher: Springer Country of Publication: United States NLM ID: 100929017 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Acoustically targeted chemogenetics for the non-invasive control of neural circuits.

  • Authors : Szablowski JO; Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.; Lee-Gosselin A

Subjects: Designer Drugs/Designer Drugs/Designer Drugs/*pharmacology ; Hippocampus/Hippocampus/Hippocampus/*metabolism ; Neurons/Neurons/Neurons/*drug effects

  • Source: Nature biomedical engineering [Nat Biomed Eng] 2018 Jul; Vol. 2 (7), pp. 475-484. Date of Electronic Publication: 2018 Jul 09.Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  725 results for ""DESIGNER drugs""